Join to View Full Profile
100 Park StCr Wood Cancer CenterGlens Falls, NY 12801
Phone+1 518-926-6620
Fax+1 518-926-1954
Dr. Stoutenburg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2002 - 2005
University of North Carolina HospitalsResidency, Internal Medicine, 1999 - 2002
SUNY Upstate Medical UniversityClass of 1999
Certifications & Licensure
NY State Medical License 2002 - 2025
NC State Medical License 1999 - 2002
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery Start of enrollment: 2011 May 25
- Join now to see all
Publications & Presentations
PubMed
- 276 citationsCharacterization of CD4+CD25+ Regulatory T Cells in Patients Treated With High-Dose Interleukin-2 for Metastatic Melanoma or Renal Cell CarcinomaGiovanni C. Cesana, Gail DeRaffele, Seth Cohen, Dorota Moroziewicz, Josephine Mitcham
Journal of Clinical Oncology. 2006-03-01 - 10 citationsAdjuvant therapy for malignant melanoma.John P. Stoutenburg, Beth Schrope, Howard L. Kaufman
Expert Review of Anticancer Therapy. 2004-10-01 - 4 citationsAntiemetic studies on the NK1 receptor antagonist aprepitant.John P. Stoutenburg, Harry Raftopoulos
Journal of the National Comprehensive Cancer Network. 2004-09-01
Press Mentions
Glens Falls Hospital Raising Money to Expand Oncology PharmacyAugust 10th, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
